Fairfax, VANCT07912593Now EnrollingIRB Ready

Metastatic Colorectal Cancer (CRC) Clinical Trial in Fairfax, VA

Access cutting-edge metastatic colorectal cancer (crc) treatment through this phase 1/2 clinical trial at a research site in Fairfax. Study-provided care at no cost to qualified participants.

Sponsored by Ensem Therapeutics

Quick Self-Assessment

See if you qualify for this Fairfax location

Preparing your pre-screening questions…

Expert Care in Fairfax

Access metastatic colorectal cancer (crc) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related metastatic colorectal cancer (crc) treatment provided free

Apply for This Fairfax Location

Check if you qualify for this metastatic colorectal cancer (crc) clinical trial in Fairfax, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fairfax

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fairfax site if eligible
  4. 4Begin participation

About This Metastatic Colorectal Cancer (CRC) Study in Fairfax

This is a Phase 1/2, open-label, multi-center study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of ETX-929 in participants with advanced solid tumors harboring a Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation.

Sponsor: Ensem Therapeutics

Who Can Participate

Inclusion Criteria

Metastatic or locally advanced and unresectable solid tumor that has progressed on or after at least one available therapy.
Tumor harboring a KRAS mutation.
An ECOG performance status score of 0 or 1.
Adequate organ function.

Exclusion Criteria

Has history (within ≤2 years before screening) of a solid tumor or hematological malignancy that is histologically distinct from the cancers being studied.
Has symptomatic brain or spinal metastases or a known or suspected history of untreated or uncontrolled central nervous system (CNS) involvement.
Has received treatment with any local or systemic anticancer therapy or investigational anticancer agent within 14 days prior to start of treatment.
Has toxicities from previous anticancer therapies that have not resolved to baseline levels with the exception of alopecia and peripheral neuropathy.
Has had radiotherapy outside the target tumor lesions within 14 days prior to start of treatment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fairfax?

Yes, this clinical trial (NCT07912593) has an active research site in Fairfax, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Metastatic Colorectal Cancer (CRC) Treatment Options in Fairfax, VA

If you're searching for metastatic colorectal cancer (crc) treatment options in Fairfax, VA, this clinical trial (NCT07912593) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fairfax research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced metastatic colorectal cancer (crc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all metastatic colorectal cancer (crc) clinical trials near you to find additional studies recruiting in your area.

More Colorectal Cancer Trials in Fairfax, VA

See all colorectal cancer clinical trials recruiting in Fairfax — not just this study.

Browse Colorectal Cancer Trials in Fairfax →

Ready to Join in Fairfax?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fairfax, VA